Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine proteases are a major class of enzymes characterized by a serine residue at their active site that participates directly in the hydrolysis of peptide bonds. They play key roles in numerous physiological processes including digestion, immune response, blood coagulation, and inflammation. The PDB entry 1O3J details the structural complexity of hydrogen bond networks mediating the binding of small molecule inhibitors to the active site of such proteases, informing the design of selective drugs targeting this enzyme class[1].
Inhibition of protease activity (serine protease inhibitors bind to the active site to block substrate access)[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine protease (specific type not given; likely needs refinement with UniProt or original PDB record).